The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration

References

• Abudalu M, Tyring S, Koltun W. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double blind, comparative trial. Clin Infect Dis. 2008;47:651–658.
   PubMed Web of Science ®Google Scholar
• Tyring SK, Beutner KR, Tucker BA, et al. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med. 2000;9:863–869.
   PubMedGoogle Scholar
• Beutner KR, Friedman DJ, Forszpaniak C, et al. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995;39:1546–1553.
   PubMed Web of Science ®Google Scholar
• Drugs for non-HIV viral infections. Treat Guidel Med Lett 2007;5:59.
   PubMedGoogle Scholar
• Sawyer MH, Webb DE, Balow JE, et al. Acyclovir-induced renal failure. Clinical course and histology. Am J Med. 1988;84:1067.
   PubMed Web of Science ®Google Scholar
• Perazella MA. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci. 2003;325:349.
   PubMed Web of Science ®Google Scholar
• Bean B, Aeppli D. Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster. J Infect Dis. 1985;151:362–365.
   PubMed Web of Science ®Google Scholar
• Acyclovir (systemic): drug information. In: Basow DS, editor. UpToDate. Waltham (MA): UpToDate; 2012.
   Google Scholar
• Lam NN, Weir MA, Yao Z, et al. Risk of acute kidney injury from oral acyclovir: a population-based study. Am J Kidney Dis. 2013;61:723–729.
   PubMed Web of Science ®Google Scholar
• Bellomo R, Ronco C, Kellum JA. et al. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204–R212.
   PubMed Web of Science ®Google Scholar
• Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459–465.
   PubMed Web of Science ®Google Scholar
• Brigden D, Rosling AE, Woods NC. Renal function after acyclovir intravenous injection. Am J Med. 1982;73:182–185.
   PubMed Web of Science ®Google Scholar
• Keeney RE, Kirk LE, Bridgen D. Acyclovir tolerance in humans. Am J Med. 1982;73:176– 181.
   PubMed Web of Science ®Google Scholar
• Izzedine H, Launay-Vacher V, Deray G. Antiviral drug-induced nephrotoxicity. Am J Kidney Dis. 2005;45:804–817.
   PubMed Web of Science ®Google Scholar
• Mason WJ, Nickols HH. Images in clinical medicine. Crystalluria from acyclovir use. N Engl J Med. 2008;358:e14.
   PubMed Web of Science ®Google Scholar
• Schetz M, Dasta J, Goldstein S, et al. Drug-induced acute kidney injury. Curr Opin Crit Care. 2005;11:555–565.
   PubMed Web of Science ®Google Scholar
• Khalili H, Bairami S, Kargar M. Antibiotics induced acute kidney injury: incidence, risk factors, onset time and outcome. Acta Med Iran. 2013;51:871–878.
   PubMedGoogle Scholar
• Lapi F, Azoulay L, Yin H, et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346:e8525.
   PubMed Web of Science ®Google Scholar
• King DW, Smith MA. Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cells. Toxicol Vitro. 2004;18:797–803.
   PubMed Web of Science ®Google Scholar
• Vallon V. Do tubular changes in the diabetic kidney affect the susceptibility to acute kidney injury? Nephron Clin Pract. 2014;127:133–138.
   PubMedGoogle Scholar
• Oliveira JF, Silva CA, Barbieri CD, et al. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother. 2009;53:2887–2891.
   PubMed Web of Science ®Google Scholar
• Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med. 1990;150:1237–1242.
   PubMedGoogle Scholar
• Vomiero G, Carpenter B, Robb I, et al. Combination of ceftriaxone and acyclovir - an underestimated nephrotoxic potential?. Pediatr Nephrol. 2002;17:633–637.
   PubMed Web of Science ®Google Scholar
• Rao S, Abzug MJ, Carosone-Link P, et al. Intravenous acyclovir and renal dysfunction in children: a matched case control study. J Pediatr. 2015;166:1462–1468.
   PubMed Web of Science ®Google Scholar
• Daghero O, Andreoni G, Arione R, et al. [Cephalosporins and enzymuria]. Minerva Med. 1986;77:231–237.
   PubMedGoogle Scholar